BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6268719)

  • 1. [Biological characterization including sensitivity to mitomycin C of cultured human ovarian cancers (author's transl)].
    Motoyama T
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1197-204. PubMed ID: 6268719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative analysis on in vitro drug sensitivity of cultured human ovarian cancer cell lines (author's transl)].
    Motoyama T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):308-14. PubMed ID: 7069245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A newly established cel line derived from human ovarian adenocarcinoma.
    Sekiguchi M; Sakakibara K; Suzuki T; Motoyama T; Fujii G
    Jpn J Exp Med; 1980 Aug; 50(4):283-92. PubMed ID: 7441907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of cultured cell lines derived from a human gastric carcinoma.
    Sekiguchi M; Sakakibara K; Fujii G
    Jpn J Exp Med; 1978 Feb; 48(1):61-8. PubMed ID: 209229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of anticancer drugs on in vitro survival of cell lines derived from various gynecologic tumors (author's transl)].
    Sekiya S; Takamizawa H
    Acta Obstet Gynaecol Jpn; 1981 Mar; 33(3):373-6. PubMed ID: 6163305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
    Huang JS
    Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene.
    Yanagihara K; Seyama T; Tsumuraya M; Kamada N; Yokoro K
    Cancer Res; 1991 Jan; 51(1):381-6. PubMed ID: 1846312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
    Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four new cell lines from patients with adenocarcinoma of the ovary.
    Woods LK; Morgan RT; Quinn LA; Moore GE; Semple TU; Stedman KE
    Cancer Res; 1979 Nov; 39(11):4449-59. PubMed ID: 498076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1).
    Bar JK; HarloziƄska A
    Anticancer Res; 2000; 20(5A):2975-80. PubMed ID: 11062710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on marker substances in cell lines derived from various human gynecologic tumors (author's transl)].
    Sekiya S; Kawata M; Inaba N; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):37-42. PubMed ID: 6174649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization.
    Shenhua X; Lijuan Q; Hanzhou N; Xinghao N; Chihong Z; Gu Z; Weifang D; Yongliang G
    J Exp Clin Cancer Res; 1999 Jun; 18(2):233-9. PubMed ID: 10464713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic characterization of tumor markers in human ovarian cancer cell lines.
    Kutteh WH; Miller DS; Mathis JM
    J Soc Gynecol Investig; 1996; 3(4):216-22. PubMed ID: 8796833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a human ovarian carcinoma cell line, OTN 14, derived from a mucinous cystadenocarcinoma.
    van Niekerk CC; Poels LG; Jap PH; Smeets DF; Thomas CM; Ramaekers FC; Vooijs GP
    Int J Cancer; 1988 Jul; 42(1):104-11. PubMed ID: 3292443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment and characterization of a cell line derived from mucinous cystadenocarcinoma of human ovary].
    Kidera Y; Yoshimura T; Ohkuma Y; Iwasaka T; Sugimori H
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1820-4. PubMed ID: 4056530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of anticancer agents on 7, 12-dimethylbenz (a) anthracene induced rat ovarian cancer cell line (DMBA-OC-1) and human ovarian serous adenocarcinoma cell line (KOC-1S)].
    Kataoka A; Yokota D; Sugiyama T; Oda T; Nishida T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1523-9. PubMed ID: 2511256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a human ovarian carcinoma cell line: UCI 101.
    Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
    Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of HUOT, a human ovarian malignant teratoma cell line producing alpha-fetoprotein.
    Ishiwata I; Ishiwata C; Soma M; Tomita K; Nozawa S; Ishikawa H
    J Natl Cancer Inst; 1985 Sep; 75(3):411-22. PubMed ID: 2411992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of a human ovarian neoplastic cell line, DO-s.
    Briers TW; Stroobants P; Vandeputte TM; Nouwen EJ; Conraads MV; Eestermans G; Van Bockstaele D; De Broe ME
    Cancer Res; 1989 Sep; 49(18):5153-61. PubMed ID: 2548714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.